Not applicableUnknownNCT04105647What this trial is testingLifestyle Modification Program for Lung Cancer Patients - A Pilot StudyWho this might be right forCancer, Lung The University of Hong Kong 32
Testing effectiveness (Phase 2)Study completedNCT00095225What this trial is testingEvaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)Who this might be right forNon-Small-Cell Lung CarcinomaNeoplasm Recurrence, Local Genentech, Inc. 122
Testing effectiveness (Phase 2)Study completedNCT00003989What this trial is testingISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaWho this might be right forLung CancerMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Ended earlyNCT06507891What this trial is testingA Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 TabletsWho this might be right forNon Small Cell Lung Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00564733What this trial is testingFDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung CancerWho this might be right forMalignant Pleural EffusionStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer University of Washington 55
Early research (Phase 1)Study completedNCT06863233What this trial is testingCD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung CancerWho this might be right forLung CancerNon Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 4
Early research (Phase 1)Active Not RecruitingNCT02817633What this trial is testingTSR-022 in Participants With Advanced Solid Tumors (AMBER)Who this might be right forNeoplasms Tesaro, Inc. 463
Testing effectiveness (Phase 2)UnknownNCT01592617What this trial is testingPhase II Study of S-488410 to Treat Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Shiga University 45
Testing effectiveness (Phase 2)Ended earlyNCT04364048What this trial is testingDurvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung CancerWho this might be right forLung CancerNon-small Cell Carcinoma Rachel Sanborn 10
Not applicableWithdrawnNCT00897143What this trial is testingIdentifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung CancerWho this might be right forLung CancerMetastatic Cancer Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT05176925What this trial is testingTislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLCWho this might be right forNon-small Cell Lung Cancer Fudan University 5
Post-approval studies (Phase 4)Looking for participantsNCT06330038What this trial is testingAnesthesia and Non-small Cell Lung Cancer RecurrenceWho this might be right forNon-small Cell Lung CancerSurgeryAnesthesia Samsung Medical Center 5,384
Testing effectiveness (Phase 2)UnknownNCT05458726What this trial is testingCorrelation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLCWho this might be right forEGFR T790MOsimertinibNon-small Cell Lung Cancer+1 more Peking Union Medical College 80
Not applicableStudy completedNCT00899535What this trial is testingCancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030Who this might be right forLung Cancer Alliance for Clinical Trials in Oncology 70
Post-approval studies (Phase 4)UnknownNCT01665417What this trial is testingIcotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung AdenocarcinomaWho this might be right forEGFR Positive Non-small Cell Lung CancerAdenocarcinoma Betta Pharmaceuticals Co., Ltd. 100
Early research (Phase 1)Ended earlyNCT04892017What this trial is testingStudy of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid TumorsWho this might be right forNon-Small Cell Lung CancerAdvanced Solid TumorMetastatic Solid Tumor Deciphera Pharmaceuticals, LLC 91
Testing effectiveness (Phase 2)Looking for participantsNCT07276789What this trial is testingEfficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer (NSCLC) Integro Theranostics 35
Not applicableStudy completedNCT04187768What this trial is testingImmunological Profile Changes In Patients With Advanced Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticHealthy Indiana University 29
Large-scale testing (Phase 3)Ended earlyNCT00345059What this trial is testingThe DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung CancerWho this might be right forAdvanced Non-Small Cell Lung Cancer National Cancer Institute, Naples 84
Not applicableLooking for participantsNCT07528066What this trial is testingDownstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLCWho this might be right forNeoadjuvant ChemoimmunotherapyRobotic Pulmonary ResectionStage IIB-III NSCLC Shanghai Chest Hospital 200